Supplementation With Lactoferrin in Preterm Newborns

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of the study is to evaluate the antioxidant effect of lactoferrin and its ability to reduce free radicals related diseases in the newborn. This evaluation will be done through the assessment of neuro-developmental follow-up.

The secondary objective is to identify a panel of markers for assessing oxidative stress and for a correlation with the lactoferrin antioxidant effect.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Siena
• Treatments: Lactoferrin

Criteria

Inclusion criteria:

• Newborns with a birthweight ≤ 1500 grand/or gestational age ≤ 32 weeks

• Sign of the informed consent by parents

Exclusion criteria:

• Fetal-onset disorders and/or recognizable at birth

• Milk intolerance

• Family history of allergies

• Use of infant formula supplemented with lactoferrin